Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 21.04.2025 6 Am J Dermatopathol 13 BMC Cancer 8 Br J Dermatol 1 Cancer 1 Cancer Lett 4 Cancer Res 7 Clin Exp Dermatol 2 Hum Mutat 1 Int J Cancer 10 Int J Dermatol 5 J Cutan Pathol 3 J Dermatol 3 J Invest Dermatol 4 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. NISHADHAM V, Helm TN, Helm MF
   A Changing Papule on the Thigh: Answer.
   Am J Dermatopathol. 2025;47:410-411.
   PubMed        
   
   
2. NISHADHAM V, Helm TN, Helm MF
   A Changing Papule on the Thigh: Challenge.
   Am J Dermatopathol. 2025;47:e52.
   PubMed        
   
   
3. FERNANDEZ-FLORES A
   Conceptual Contextualization of Neutrophilic Dermatoses.
   Am J Dermatopathol. 2025;47:337-354.
   PubMed         Abstract available
   
   
4. SUN S, Odom J, Ruiz N, Moody P, et al
   Dermatofibrosarcoma Protuberans Arising in a Digit: A Case Report.
   Am J Dermatopathol. 2025;47:355-357.
   PubMed         Abstract available
   
   
5. LENSKAYA V, Yang RK, Aung PP, Prieto VG, et al
   NSD3::FGFR1 : A Novel Gene Fusion First to Be Described in Merkel Cell Carcinoma.
   Am J Dermatopathol. 2025;47:400-403.
   PubMed         Abstract available
   
   
6. RONEN S, Stieber D, Ferrier M, Nogales-Moro A, et al
   Matrical Tumors: A Comparative Molecular Analysis of Six Cases With Histological Correlations.
   Am J Dermatopathol. 2025;47:365-372.
   PubMed         Abstract available
   
   

   
   BMC Cancer

7. KAVAK EE, Urun Y
   Classical Kaposi sarcoma: an insight into demographic characteristics and survival outcomes.
   BMC Cancer. 2025;25:690.
   PubMed         Abstract available
   
   
8. ZHU W, Fang J, Zhang Y, Chen M, et al
   Validation of in vivo dose using EPID combined with fan-beam CT guidance in post-breast-conserving radiotherapy for early-stage breast cancer.
   BMC Cancer. 2025;25:667.
   PubMed         Abstract available
   
   
9. BOSSON-AMEDENU S, Ayitey E, Ayiah-Mensah F, Asare L, et al
   Evaluating key predictors of breast cancer through survival: a comparison of AFT frailty models with LASSO, ridge, and elastic net regularization.
   BMC Cancer. 2025;25:665.
   PubMed         Abstract available
   
   
10. REN W, Yu Y, Wang T, Wang X, et al
    Comprehensive analysis of metabolism-related gene biomarkers reveals their impact on the diagnosis and prognosis of triple-negative breast cancer.
    BMC Cancer. 2025;25:668.
    PubMed         Abstract available
    
    
11. GETU MA, Kaba M, Addissie A, Seife E, et al
    Patients' experiences of cognitive behavioural therapy integrated with activity pacing: a qualitative study.
    BMC Cancer. 2025;25:670.
    PubMed         Abstract available
    
    
12. LIN X, Yang H, Cai T, Yang Z, et al
    Polygonum multiflorum Stilbene Glycoside Oligomers induce the ferroptosis of triple negative breast cancer cells.
    BMC Cancer. 2025;25:676.
    PubMed         Abstract available
    
    
13. LI Z, Miao H, Bao W, Zhang L, et al
    Development and validation of a nomogram model of lung metastasis in breast cancer based on machine learning algorithm and cytokines.
    BMC Cancer. 2025;25:692.
    PubMed         Abstract available
    
    
14. TANG H, Zhang W, Li X, Zou Q, et al
    Impact of early multidisciplinary team interventions on dietary management behavior in breast cancer patients: a pilot randomized controlled trial.
    BMC Cancer. 2025;25:699.
    PubMed         Abstract available
    
    
15. SAGDIC MF, Dincer B, Ozaslan C
    De-escalation of axillary surgery in early breast cancer: translating ACOSOG Z0011 study into clinical practice for breast-conserving surgery patients with positive sentinel lymph node biopsy.
    BMC Cancer. 2025;25:706.
    PubMed         Abstract available
    
    
16. RASHID FA, Anwar W, Kandakurti PK, Al Qawasmeh KHA, et al
    Physical rehabilitation program for cardiorespiratory health and quality of life among breast cancer survivors in UAE: a randomized control trial.
    BMC Cancer. 2025;25:705.
    PubMed         Abstract available
    
    
17. LIU J, Guan X, Gao S, Quan L, et al
    Novel insight of critical genes involved in breast cancer brain metastasis: evidence from a cross-tissue transcriptome association study and validation through external clinical cohorts.
    BMC Cancer. 2025;25:707.
    PubMed         Abstract available
    
    
18. LIAN W, Li L, Chen D, Hong C, et al
    Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a multi-center retrospective study.
    BMC Cancer. 2025;25:723.
    PubMed         Abstract available
    
    
19. CASTELLANO I, Rousset S, Casella D, Capella G, et al
    Early detection of triple-negative breast cancer: evidence of a favourable prognostic impact in a comparative analysis of screen-detected versus symptomatic cases.
    BMC Cancer. 2025;25:730.
    PubMed         Abstract available
    
    

    
    Br J Dermatol

20. PILERI A, Zengarini C
    Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
    Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
    PubMed        
    
    
21. KARPONIS D, van Bodegraven B, Mistry K, Nikolaou V, et al
    Incidence and mortality of melanoma in situ and malignant melanoma in England between 2001 and 2020.
    Br J Dermatol. 2025 Apr 15:ljaf136. doi: 10.1093.
    PubMed         Abstract available
    
    
22. CHEN J, Liu X, Bai Y, Tang X, et al
    Tonsillar Microbiota Alterations Contribute to Immune Responses in Psoriasis by Skewing Aged Neutrophils.
    Br J Dermatol. 2025 Apr 15:ljaf134. doi: 10.1093.
    PubMed         Abstract available
    
    
23. ZHU J, Abuabara K
    Complex comorbidities: Could a diabetes drug help prevent atopic dermatitis?
    Br J Dermatol. 2025 Apr 15:ljaf131. doi: 10.1093.
    PubMed        
    
    
24. FARIYIKE O, Johnson NA, Van Bodegraven B, Quirke K, et al
    The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England.
    Br J Dermatol. 2025 Apr 15:ljaf135. doi: 10.1093.
    PubMed        
    
    
25. DUGOURD PM, Guardoli D, Fontas E, Marie-Luce S, et al
    Promoting Repigmentation after Epidermal cell suspension grafting and preVENTing the loss of melanocytes using topical ruxolitinib for vitiligo in resistant areas (PREVENT). A prospective monocentric interventional double-blind study.
    Br J Dermatol. 2025 Apr 17:ljaf143. doi: 10.1093.
    PubMed        
    
    
26. NASLUND-KOCH C, Kvist-Hansen A, Bojesen SE, Skov L, et al
    Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100,000 individuals.
    Br J Dermatol. 2025 Apr 18:ljaf147. doi: 10.1093.
    PubMed         Abstract available
    
    
27. LEMARCQ L, Reynaert V, Van den Steen E, Evers-Lebrun C, et al
    Outcome Measures for Interdisciplinary Care in Immune-mediated Inflammatory Skin Diseases (skIMIDs): A Scoping Review.
    Br J Dermatol. 2025 Apr 18:ljaf153. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer

28. PALESH O, Braun SE, Truong T, Hong S, et al
    Natural trajectory subclasses of cognitive impairment in breast cancer patients experiencing insomnia.
    Cancer. 2025;131:e35816.
    PubMed         Abstract available
    
    

    
    Cancer Lett

29. UEMOTO Y, Lin CA, Wang B, Ye D, et al
    Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations.
    Cancer Lett. 2025;619:217668.
    PubMed         Abstract available
    
    

    
    Cancer Res

30. SOUTO EP, Gong P, Landua JD, Rajaram Srinivasan R, et al
    Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor-Initiating Cells Characterized by IFN/STAT1 Activity.
    Cancer Res. 2025;85:1390-1409.
    PubMed         Abstract available
    
    
31. IPPOLITOV D, Lin YH, Spence J, Glogowska A, et al
    The Brain-Penetrant Pan ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases.
    Cancer Res. 2025 Feb 11. doi: 10.1158/0008-5472.CAN-24-1793.
    PubMed         Abstract available
    
    
32. METGE BJ, Williams L, Swain CA, Hinshaw DC, et al
    Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to Support Breast Cancer Progression.
    Cancer Res. 2025 Feb 4. doi: 10.1158/0008-5472.CAN-24-0707.
    PubMed         Abstract available
    
    
33. TABET I, Orhan E, Candiello E, Fenou L, et al
    Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection that Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-24-1404.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

34. VILLANI A, Genco L, Fornaro L, Potestio L, et al
    How the use of sonidegib beyond clinical complete response impacts tolerability in locally advanced basal cell carcinoma: A retrospective monocentric analysis.
    Clin Exp Dermatol. 2025 Apr 15:llaf171. doi: 10.1093.
    PubMed        
    
    
35. ORSINI D, Graceffa D, Burlando M, Campanati A, et al
    BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
    Clin Exp Dermatol. 2025 Apr 15:llaf168. doi: 10.1093.
    PubMed        
    
    
36. SENDIN-MARTIN M, Bueno Molina R, Hernandez-Rodriguez JC, Cayuela L, et al
    Trends in Cutaneous Malignant Melanoma Mortality in Europe from 1992 to 2021.
    Clin Exp Dermatol. 2025 Apr 16:llaf170. doi: 10.1093.
    PubMed         Abstract available
    
    
37. MA SH, Yeh CH, Chen TL, Wu CY, et al
    Long-term cardiovascular outcomes among adult survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective cohort study using TriNetX.
    Clin Exp Dermatol. 2025 Apr 16:llaf046. doi: 10.1093.
    PubMed         Abstract available
    
    
38. MORTATO E, Talamonti M, Marcelli L, Megna M, et al
    A Long-Term Real-Life Safety Study of Guselkumab in Psoriasis Patients with Infectious Comorbidities, Malignancies or Heart Disease: The EARLY Study.
    Clin Exp Dermatol. 2025 Apr 16:llaf172. doi: 10.1093.
    PubMed         Abstract available
    
    
39. KO MJ, Tsai WC, Tsai PH, Hsu LY, et al
    Risk of Nonmelanoma Skin Cancers and Cutaneous Melanoma after Psoralen and Ultraviolet A Therapy in Psoriasis Patients: A Nationwide Taiwanese Cohort Study.
    Clin Exp Dermatol. 2025 Apr 16:llaf169. doi: 10.1093.
    PubMed         Abstract available
    
    
40. SHARIF Z, Larkin J, Pickering L, Young K, et al
    Grade 3 and Grade 4 Cutaneous toxicities in patients across multiple solid tumour types receiving checkpoint inhibitor therapy: An observational study. The experience of a single large specialist institution.
    Clin Exp Dermatol. 2025 Apr 17:llaf173. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Hum Mutat

41. LONNING PE, Nikolaienko O, Knappskog S
    Constitutional BRCA1 Epimutations: A Key for Understanding Basal-Like Breast and High-Grade Serous Ovarian Cancer.
    Hum Mutat. 2024;2024:7353984.
    PubMed         Abstract available
    
    
42. CLOWES V, Ma X, Maude H, Dennis C, et al
    Homozygous HOXC13 Variant Causes Pure Hair and Nail Ectodermal Dysplasia via Reduction in Protein Stability.
    Hum Mutat. 2024;2024:6420246.
    PubMed         Abstract available
    
    

    
    Int J Cancer

43. STAERK MG, Kaderly Rasmussen EL, Hannibal CG, Hertzum-Larsen R, et al
    Histologically verified penile lichen sclerosus-Incidence in Denmark over 26 years and long-term risk of penile and non-penile cancer.
    Int J Cancer. 2025 Apr 18. doi: 10.1002/ijc.35454.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

44. FLUHR JW, Muguet V, Christen-Zaech S
    Restoring Skin Hydration and Barrier Function: Mechanistic Insights Into Basic Emollients for Xerosis Cutis.
    Int J Dermatol. 2025 Apr 15. doi: 10.1111/ijd.17790.
    PubMed         Abstract available
    
    
45. MARTINEZ VILLARREAL JD, Cardenas-de la Garza JA, Ionescu MA, Tatu AL, et al
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Current Management and Innovative Therapies.
    Int J Dermatol. 2025 Apr 15. doi: 10.1111/ijd.17768.
    PubMed         Abstract available
    
    
46. TANG JT, Xu MY, Wu NH, Wu F, et al
    Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis.
    Int J Dermatol. 2025 Apr 16. doi: 10.1111/ijd.17742.
    PubMed        
    
    
47. PASCHOU IA, Drantaki VI, Gerochristou M, Stefanaki I, et al
    Dual Immune-Related Toxicities: Secukinumab-Induced Bullous Pemphigoid Following ICI-Associated Psoriasis in a Cancer Patient.
    Int J Dermatol. 2025 Apr 16. doi: 10.1111/ijd.17778.
    PubMed        
    
    
48. MELGOSA RAMOS FJ, Vila Cobreros L, Pascual MG, Guillen-Climent S, et al
    Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate-To-Severe Atopic Dermatitis: A Multicenter Study.
    Int J Dermatol. 2025 Apr 16. doi: 10.1111/ijd.17797.
    PubMed        
    
    
49. AMARA S, Kodali N, Lopez M, Hawkins K, et al
    Management of Eczematous Reactions Secondary to Biologic Use in Psoriasis Patients: A Retrospective Study.
    Int J Dermatol. 2025 Apr 16. doi: 10.1111/ijd.17727.
    PubMed        
    
    
50. CHERRADI R, Bouchelkia I, Haque S, Ezuruike J, et al
    A Dark Side of Calcium Channel Blockers: Increased Risk of Stasis Dermatitis.
    Int J Dermatol. 2025 Apr 16. doi: 10.1111/ijd.17738.
    PubMed        
    
    
51. REGESTER RM, Antonson M, Harter NN
    Clinicopathological Challenge: Five Males Presenting With Progressive Skin Thickening and Hoarse Voices.
    Int J Dermatol. 2025 Apr 18. doi: 10.1111/ijd.17766.
    PubMed         Abstract available
    
    
52. GUIDA S, Ciardo S, Galadari H, De Pace B, et al
    Correlating Optical Coherence Tomography and Other Noninvasive Imaging Features With Atrophic and Hypertrophic Skin Photoaging.
    Int J Dermatol. 2025 Apr 18. doi: 10.1111/ijd.17799.
    PubMed         Abstract available
    
    
53. CANAL-GARCIA E, Del Alcazar-Viladomiu E, Izu RM, Llamas-Velasco M, et al
    Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares: An Observational, Retrospective, and Multicenter Study of Effectiveness and Safety in Real-World Clinical Practice.
    Int J Dermatol. 2025 Apr 18. doi: 10.1111/ijd.17795.
    PubMed        
    
    

    
    J Cutan Pathol

54. NASIMI M, Bandani S, Kamyab K, Etesami I, et al
    Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases.
    J Cutan Pathol. 2025;52:386-391.
    PubMed         Abstract available
    
    
55. YAVUZ G, Toprak M, Zemheri E, Can Kuru B, et al
    Granulomatous Eccrine Hidradenitis. A New Histopathological Entity?
    J Cutan Pathol. 2025;52:362-366.
    PubMed         Abstract available
    
    
56. SCARFO F, Brunetto E, Magliacane G, Pecciarini L, et al
    Spitz Spindle Cell/Reed Nevus With SQSTM1 :: NTRK2 Fusion and Atypical Features in an Older Male Patient: A Case Report and Review of Literature.
    J Cutan Pathol. 2025;52:367-373.
    PubMed         Abstract available
    
    
57. PRECHTEL TJ, Brashear E, Dehner CA, Alomari AK, et al
    A Case of Hybrid Cellular Neurothekeoma and Perineurioma With a Folliculin Gene Mutation.
    J Cutan Pathol. 2025;52:374-378.
    PubMed         Abstract available
    
    
58. WILLIAMSON S, Rosenberg A, Jassim S, Somach S, et al
    CD138: A Potential Novel Diagnostic Marker for Cellular Neurothekeoma.
    J Cutan Pathol. 2025;52:379-383.
    PubMed         Abstract available
    
    

    
    J Dermatol

59. LIAO V, Lavin L, Ong MM, Pulitzer MP, et al
    Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience.
    J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17747.
    PubMed         Abstract available
    
    
60. MORTATO E, Marcelli L, Tofani L, Belcastro A, et al
    Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study.
    J Dermatol. 2025 Apr 16. doi: 10.1111/1346-8138.17752.
    PubMed         Abstract available
    
    
61. SHEN MH, An HY, Shih CL
    Increased Incidence of COVID-19 Infection in Atopic Dermatitis Patients: A Real-World Cohort Study With Risk Factor Analysis.
    J Dermatol. 2025 Apr 12. doi: 10.1111/1346-8138.17738.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

62. WANG J, Zhang Y, Xie F, Liu J, et al
    Enhancing Diagnosis of Psoriasis and Inflammatory Skin Diseases: A Spatially Aligned Multimodal Model Integrating Clinical and Dermoscopic Images.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00402.
    PubMed         Abstract available
    
    
63. DEBERG HA, Fahning ML, Varkhande SR, Schlenker JD, et al
    T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00401.
    PubMed         Abstract available
    
    
64. DONG L, Wu N, Cai Z, Yan S, et al
    Tolerogenic monocyte-derived langerhans cells promote melanoma progression and immunotherapy resistance through AhR-COX2 activation.
    J Invest Dermatol. 2025 Apr 9:S0022-202X(25)00404.
    PubMed         Abstract available
    
    

    
    PLoS One

65. MAHAR B, Osman MB, Ahmad Fauzi FB
    Effectiveness of theory-based breast self-examination intervention for breast cancer prevention among female college teachers in Pakistan: A cluster randomized controlled trial study protocol.
    PLoS One. 2025;20:e0321634.
    PubMed         Abstract available
    
    
66. SINGH A, Dwivedi RK, Singh VK, Sharma M, et al
    Modeling and simulation of an effectual triangular slotted UWB flexible antenna for breast cancer detection and healthcare monitoring.
    PLoS One. 2025;20:e0320806.
    PubMed         Abstract available
    
    
67. ZHU G, Dong Y, Zhu R, Tan Y, et al
    Dynamic contrast-enhanced magnetic resonance imaging parameters combined with diffusion-weighted imaging for discriminating malignant lesions, molecular subtypes, and pathological grades in invasive ductal carcinoma patients.
    PLoS One. 2025;20:e0320240.
    PubMed         Abstract available
    
    
68. RASTOGI A, Ravindranath V, Dubey A, Gude D, et al
    A real-world multicenter cross-sectional observational study to assess the clinical profile of peripheral neuropathy in patients with diabetes.
    PLoS One. 2025;20:e0312085.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

69. YI J, Du J, Chen X, Nie RC, et al
    A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2420383122.
    PubMed         Abstract available
    
    
70. CHEN YF, Zhang QH, Zhang ZW, Zhou YJ, et al
    SNX10 deficiency impairs sensitivity to anti-HER2 antibody-drug conjugates via altering HER2 trafficking in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2417586122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.